Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Stefan N, Yki-Järvinen H, Neuschwander-Tetri BA
Lancet Diabetes Endocrinol. Pub. online 13 Dec 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control-IQ and MiniMed 780G according to patient characteristics
Gargouri I, Charfi H, Belabed W, et al.
Diabetes Obes Metab. Pub. online 17 Dec 2024.
Leggi
Association between glycemia, glycemic variability, and pregnancy complications in early GDM
Immanuel J, Cheung NW, Mohajeri M, et al.
Diabetes Care. 2024:dc241199
Leggi
Finerenone, obesity, and heart failure with mildly reduced/preserved ejection fraction: prespecified analysis of FINEARTS-HF
Butt JH, Henderson AD, Jhund PS, et al.
J Am Coll Cardiol. 2024:S0735-1097(24)10423-8.
Leggi
Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents
Franceschi R, Pertile R, Marigliano M, et al.
Diabetes Res Clin Pract. 2024:111962.
Leggi
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes
Redondo MJ, Cuthbertson D, Steck AK, et al.
Diabetologia. Pub. online 13 Dec 2024.
Leggi
Conservative surgery for forefoot osteomyelitis may increase reulceration-free survival compared to minor amputation in diabetes-related foot disease
Víquez-Molina G, Rojas-Bonilla JM, Aragón-Sánchez J
Diabetes Res Clin Pract. 2024:111949.
Leggi
Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: a population-based cohort study
Yu YH, Platt RW, Reynier P, et al.
Diabetes Obes Metab. Pub. online 16 Dec 2024.
Leggi
Gestational diabetes, the human milk metabolome, and infant growth and adiposity
Nagel EM, Peña A, Dreyfuss JM, et al.
JAMA Netw Open. 2024;7(12):e2450467.
Leggi
Risk of nephrolithiasis associated with SGLT2 inhibitors versus DPP4 inhibitors among patients with type 2 diabetes: a target trial emulation study
Shin A, Shin JY, Kang EH
Diabetes Care. 2024:dc241652.
Leggi